Back to Search
Start Over
A case for genotype-guided de-escalation of antiplatelet therapy after percutaneous coronary angioplasty.
- Source :
-
Future cardiology [Future Cardiol] 2019 Jul; Vol. 15 (4), pp. 251-254. Date of Electronic Publication: 2019 Aug 06. - Publication Year :
- 2019
- Subjects :
- Clopidogrel adverse effects
Clopidogrel pharmacokinetics
Drug Labeling
Drug Monitoring
Hemorrhage chemically induced
Humans
Percutaneous Coronary Intervention
Pharmacogenomic Testing
Platelet Aggregation Inhibitors adverse effects
Platelet Function Tests
Practice Guidelines as Topic
Prasugrel Hydrochloride adverse effects
Prasugrel Hydrochloride pharmacokinetics
Ticagrelor adverse effects
Ticagrelor pharmacokinetics
Acute Coronary Syndrome therapy
Cytochrome P-450 CYP2C19 genetics
Dual Anti-Platelet Therapy
Genotype
Platelet Aggregation Inhibitors pharmacokinetics
Subjects
Details
- Language :
- English
- ISSN :
- 1744-8298
- Volume :
- 15
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Future cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 31385522
- Full Text :
- https://doi.org/10.2217/fca-2019-0017